Human Pharmacology Trial of Calcium-vitamin D3 Tablet in Healthy Participants
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate that the intestinal absorption of calcium from a
newly developed calcium carbonate-vitamin D3 chewable tablet formulation increases the amount
of calcium excreted in urine and decreases parathyroid hormone (PTH) in serum as compared to
baseline.
Phase:
Phase 1
Details
Lead Sponsor:
Takeda
Treatments:
Calcium Calcium, Dietary Cholecalciferol Ergocalciferols Vitamin D Vitamins